COVID-19 Vaccine Effect, Response and Safety (COVERS) Sweden: clinical and epidemiological studies with special focus on vulnerable groups

Grant number: 2021-04665

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    N/A
  • Known Financial Commitments (USD)

    $1,803,000
  • Funder

    TUBITAK
  • Principal Investigator

    Class Ahlm
  • Research Location

    Sweden
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics
  • Research Subcategory

    Immunity
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

12 Publications linked via Europe PMC

COVID-19 vaccination coverage and the effect on regional disparities in morbidity and mortality among older people in Sweden, 2021-2023.

Barriers and motivators associated with COVID-19 vaccination-a vaccine acceptance scoring system based on a population survey in southern Sweden.

Anti-SARS-CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 vaccination.

Sociodemographic differences in the response to changes in COVID-19 testing guidelines.

Excess mortality in Denmark, Finland, Norway and Sweden during the COVID-19 pandemic 2020-2022.

Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.

COVID-19 vaccine uptake in Skåne county, Sweden, in relation to individual-level and area-level sociodemographic factors: a register-based cross-sectional analysis.

Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave - a nested case-control study among vaccinated adults in Sweden.

Age and sex differences in cause-specific excess mortality and years of life lost associated with COVID-19 infection in the Swedish population.